MolGen showcases high throughput testing, industry systems, reagents, consumables and complete workflows at SLAS 2022

MolGen showcased its high-tech laboratory automation technology, customized diagnostic workflow and its latest products and services to technology professionals and life science researchers at SLAS 2022 in Boston, US, in February. MolGen displayed its complete diagnostics workflow and molecular automation product offerings for human diagnostics and pharmaceutical sciences that are available worldwide.

MolGen is a global total solution provider of innovative extraction DNA/RNA technology, systems, products and kits for human and animal diagnostics, the agriculture and biotech industries.

In the areas of human diagnostics, industry and laboratory sciences, MolGen offers integrated state-of-the-art molecular purification products and systems that achieve greater efficiency, automation and scaling-up in human disease testing and diagnosis. Its extraction and testing solutions, products and equipment are designed to achieve high throughput, increased automation, reduced time to result, high yields and effective reproducibility. MolGen’s systems and consumables are versatile, efficient, highly accurate, reliable and universally applicable to empower next-generation research genetics and improve the health and wellbeing of all.

“Solving the need for high throughput testing, our scalable reagents, systems and workflows represent true innovations in laboratory technology that will transform the day-to-day of professional laboratories worldwide,” said Niels Kruize, MolGen CCO.